INTRODUCTION
Twenty years ago hydrodynamic studies by Vinograd and co-workers (160) showed that closed, circular DNA molecules are more compact than their nicked or linear counterparts. When examined by electron microscopy, the closed, circular DNA molecules appeared to be twisted (166) . The term supercoiling was coined to signify this compaction and twisting, and subsequent studies showed that supercoiling is a ubiquitous property of DNA extracted from natural sources whenever DNA molecules lack ends capable of rotation. Enzymes that regulate supercoiling were discovered by Wang (163) and Gellert et al. (42) , and many details are now known about the biochemistry of these enzymes called topoisomerases (reviewed in references 17 and 38) . From biochemical characterizations, methods were developed to perturb topoisomerase function in living cells, and it is now clear that DNA supercoiling plays a central role in bacterial chromosome biology. This review focuses on the physiology of supercoiling and the cellular events associated with perturbations of topoisomerase activities.
Before describing topoisomerases and the tools used to inactivate them, it is useful to introduce the concept of supercoiling by restating key biophysical points made previously (2, 38) . The topology of closed, circular DNA is described by the relationship W= L-T (1) where W is writhe (the geometric contortion of the helix axis), L is the linking number (the number of times one strand of the double helix passes over the other if the molecule were constrained to lie on a plane), and T is twist (the number of helical turns in the molecule in its native conformation). Supercoiling, which is the intuitive expression for W, arises when L #& T. Currently, Wand T cannot be readily measured; consequently, supercoiling is more commonly described by the relationship T = L -Lo (2) where T, the number of titratable superhelical turns, is the difference between L, the linking number of the topoisomer in question, and Lo, the linking number of a relaxed topoisomer, a closed, circular DNA created by ligation of a nicked circle (for discussion see references 38 and 165) . In all natural cases, supercoiling arises when topologically constrained DNA has a deficiency of duplex turns relative to relaxed DNA (L < Lo, equation 2) . By convention, supercoiling arising from a deficiency of duplex turns is said to be negative. This is the type of supercoiling found in cellular DNA. Positive supercoiling, which arises when constrained DNA has an excess of duplex turns, can be generated under laboratory conditions, but there is no evidence that it plays a major role in living organisms.
For DNA having free ends that can rotate, the number of primary helical turns per unit length (and therefore per DNA molecule) is a function of environmental parameters such as temperature, ionic strength, and concentration of certain DNA-binding ligands. Consequently, relaxed topoisomers formed under different environmental conditions will have different numbers of duplex turns; the value of Lo in equation 2 will vary with environmental conditions. However, no strand rotation can occur in a closed, circular DNA molecule, so values of L are unaffected by environmental changes. Instead, they are changed by transient strand breakage catalyzed by DNA topoisomerases. Thus, supercoiling can be altered either by topoisomerase activity that changes L or by environmental factors that change Lo. It is not accurately reflect the superhelical tension experienced by the DNA in vivo. In the following sections linking differences (Xr) inferred from hydrodynamic measurements will be referred to as titratable supercoils to distinguish them from superhelical tension occurring in vivo, a parameter that has not been measured frequently.
Another important point is that supercoiled DNA has a greater free energy than relaxed DNA: supercoiling is spontaneously lost whenever a nick occurs in the DNA. In a sense, supercoiled DNA is under strain and is energetically activated. Processes which unwind DNA (DNA replication and transcription) are expected to be energetically favored in negatively supercoiled DNA molecules relative to linear or relaxed DNA because these processes relieve negative superhelical strain. This type of chromosome activation can be achieved only in DNA molecules that are circular or otherwise topologically constrained.
Four bacterial DNA topoisomerases have been isolated from Eschericheria coli extracts: (i) DNA topoisomerase I (omega protein or swivelase; 163); (ii) gyrase (DNA topoisomerase II; 42); (iii) DNA topoisomerase II' (5, 39) ; and (iv) DNA topoisomerase III (19) . In addition, topoisomerase activities are encoded by bacteriophage T4 (product of phage genes 39, 52, and 60 [for review see reference 76), bacteriophage A (product of the int gene [for review see reference 110) , and transposon Tn3 (resolvase [19] (31, 32, 39, 75, 100, 115) or by treating cells with specific antibiotics. Drugs that affect the gyrA protein are nalidixic acid, oxolinic acid, and a number of related compounds (41, 151, 174) . Novobiocin, coumermycin Al, and chlorobiocin inhibit the gyrB protein (29, 43, 115) . No specific inhibitors have been found for topoisomerase I, but this activity is eliminated by mutations in the topA gene (108, 148, 157) . A third activity, topoisomerase II', is composed of the gyrA protein and a fragment of the gyrB protein; it is sensitive to inhibitors of the gyrA but not the gyrB protein (39) . Since (138) . A DNA nicking study suggests that this might be the case (121) . DNA None of these studies indicates whether superhelical tension is a general property of the entire chromosome, whether it is restricted to specific regions, or whether levels of tension vary slightly from one region to another. To address these questions, nucleotide sequence-specific probes must be developed that are sensitive to changes in superhelical tension.
Soon after the discovery of gyrase (42) , it was realized that the subunits of this enzyme are the targets of well-known antibiotics (41, 43, 151) . Cells treated with inhibitors of gyrase exhibit two effects on supercoiling. First, specific inactivation of either subunit of gyrase blocks the introdution of titratable supercoils into relaxed, circular bacteriophage lambda DNA during superinfection of a lysogen (41, 43) . Second, inhibition of either subunit leads to a loss of titratable supercoils from the bacterial chromosome (25, 88) and from plasmid DNA molecules (65, 84, 121) . In some of these antibiotic studies gyrase was shown to be the target of the drugs: identical experiments on mutants with drugresistant gyrase genes show no change in titratable supercoiling. Subsequently, temperature-sensitive gyrase mutants became available. As expected, incubation of either gyrA or gyrB mutants at restrictive temperature blocks the introduction of titratable supercoils into small, circular DNA molecules (36, 40, 62) and leads to a loss of titratable supercoils from chromosomes (147, 161) Not all topA mutants fit the pattern described above (Fig.  1) . In E. coli, a topA deletion mutant exhibits a 25% reduction in titratable supercoiling relative to wild-type cells, a result opposite to that described in the preceding paragraph (124) (step 3, Fig. 1 48, 1984 on October 16, 2017 by guest http://mmbr.asm.org/ Downloaded from ing back to normal levels, suggesting that a suppressor mutation had occurred (step 4, Fig. 1 ). The presence of suppressor mutations, some of which map in gyrA and some in gyrB (22, 124) , reduces the level of titratable supercoiling (124) . The suppressor mutations appear to compensate for the loss of topoisomerase I activity, as judged by effects on cell growth. For example, deletions in topA are easily transduced into strains containing a suppressor mutation by selecting for flanking markers. However, similar transductions into wild-type strains produce slow-growing AtopA transductants colonies. Upon subculturing, these AtopA transductants begin to grow rapidly, presumably because members of the clones have acquired the appropriate suppressor mutation (22) .
In the studies described above, DNA linking numbers were perturbed (L, equation 2); the conclusion that topoisomerases affect DNA superhelical tension rests on the assumption that no significant changes occurred in the pitch of the DNA helix (Lo, equation 2) . Recently, we have taken a different approach and have treated cells in ways expected to affect the pitch of the DNA helix to see whether the level of superhelical tension is tightly controlled. In vitro, temperature changes alter helical twist and supercoiling in a welldefined manner (20, 126) . In terms of the equations presented above, lowering the growth temperature should tighten the DNA helix, increasing Lo (equation 2). At the lower temperature X (equation 2) should become more negative; i.e., supercoiling should increase. However, if superhelical tension is tightly regulated by the action of topoisomerases, then DNA linking numbers should be higher at the lower temperature to offset the effect of temperature on helical pitch. We find this to be the case when plasmids are extracted from cells grown at different temperatures and differences in linking numbers are measured (43b) . The magnitude and direction of the linking change are consistent with the idea that topoisomerases maintain a constant level of superhelical tension in DNA. When cells are shifted from 17 to 37°C, linking numbers equilibrate in 10 to 30 min, presumably through increased gyrase activity. In a downshift, equilibration occurs in 1 to 2 h, presumably as topoisomerase I (or perhaps topoisomerase III) corrects for the change.
To summarize, the simplest interpretation of data obtained with bacterial systems is that gyrase increases DNA superhelical tenison by lowering DNA linking numbers and topoisomerase I carries out the opposite reaction. The two activities are balanced to produce an optimal level of superhelical tension. The topoisomerases maintain a tight distribution of topoisomers (about ± 10% in plasmids [124] ). Moreover, there is little deviation in supercoiling from one wildtype strain to another. We have found that the average ethidium concentration required to titrate the supercoils in isolated nucleoids from eight strains of E. coli K-12 has a standard deviation of <2% (unpublished data). A mutation in topA that partially inactivates topoisomerase I activity allows gyrase to introduce higher-than-normal levels of superhelical tension. In the case of deletion of topA in E. coli, the level of superhelical tension may become unacceptably high, halting cell growth. Compensatory mutations then arise in gyrA and gyrB that lower the level of superhelical tension and allow cell growth.
Whereas there is little doubt that superhelical tension is important to cell physiology, few details are known about precisely how topoisomerases control superhelical tension.
We sense that gyrase and topoisomerase I compete, but we are left with the nagging question of where topoisomerase III fits into the scheme.
CONTROL OF TOPOISOMERASE GENE EXPRESSION
The relationships between topoisomerase mutations and titratable supercoiling in DNA described above raise the question of how superhelical tension is controlled. Since part of the answer may lie in the regulation of topoisomerase gene expression, Gellert and his colleagues have focused on the regulation of gyrase. Both in vitro and in vivo studies suggest that DNA supercoiling itself is important in controlling gyrase expression: lowering levels of supercoiling leads to an increase in gyrase production. When plasmids carrying either gyrA or gyrB are added to a coupled transcriptiontranslation system in vitro, more gyrase is synthesized from relaxed DNA than from supercoiled DNA (98) . In vivo studies (summarized in Fig. 1 ) show that inhibition of gyrase by coumermycin Al or by incubation of a temperaturesensitive gyrB mutation at restrictive temperature leads to an increase in both gyrA and gyrB proteins (98) . Both of these treatments lower titratable supercoiling in chromosomal DNA (25, 147, 161) . A smaller increase in gyrase expression is observed when gyrase is inactivated by nalidixic acid (98) . Oxolinic acid, and probably nalidixic acid, also relaxes chromosomal DNA (88) at the drug concentrations used by Menzel and Gellert (98) . It is not clear whether relaxation associated with DNA cleavage occurs in vivo under the conditions used by Menzel and Gellert (98); moderate concentrations of oxolinic acid, which is a more potent drug than nalidixic acid, do not result in DNA cleavage unless nucleoids are exposed to protein-denaturing agents (see next section; 88, 145) .
Since reduced levels of supercoiling lead to increased gyrase expression, it has been proposed that a homeostatic relationship exists between the two (98) . If this is the case, then cells having higher-than-normal levels of supercoiling should contain lower-than-normal amounts of gyrase. This possibility can now be explored with cells having mutations in topA.
The effect of gyrA expression on gyrB expression and vice versa has also been examined (40, 98) . Isotope uptake into gyrA and gyrB proteins was measured in cells harboring a multicopy plasmid into which either gyrA or gyrB had been cloned. Under these conditions either the gyrA or the gyrB protein was overproduced. An asymmetric result was observed: overproduction of gyrB reduces gyrA expression by about threefold, but overproduction of gyrA has no effect on gyrB expression. The first result can be explained if overproduction of gyrB leads to increased levels of supercoiling which in turn decrease the expression of gyrase. The second result can be explained if overproduction of the gyrA protein has no effect on supercoiling. Such a situation could occur if the gyrA protein is normally in excess relative to the gyrB protein, a supposition consistent with data from enzyme purification studies (55, 146) . Although measurements of chromosomal DNA supercoiling have not been made under these conditions, we may find that the concentration of gyrB protein, not gyrA protein, is involved in controlling the level of supercoiling. Another possibility to be tested is that excess gyrB protein decreases the stability of the gyrA protein.
Topoisomerase I also affects gyrase gene expression, but it is not clear that the effect is mediated by changes in DNA supercoiling. Gellert et al. (39) compared the synthesis of gyrA and gyrB proteins in AtopA and topA+ strains (both contained a compensatory mutation in gyrB). Introduction of topA+ into the topA deletion mutant by transduction increased both gyrA and gyrB expression by about threefold (step 4, Fig. 1 ). In addition, supercoiling activity in a cell extract from the topA+ strain was found to be 5 to 10 times higher than that from the AtopA strain, and in vivo gyrase activity increased due to introduction of topA+ when the formation of titratable supercoils in superinfecting bacteriophage lambda was measured. Thus, it appears that gyrase gene expression and the resulting supercoiling activity are enhanced by the presence of topoisomerase I. Increased gyrase and increased topoisomerase I activities seem to counterbalance each other, for a similar pair of AtopA-topA+ strains exhibit no difference in average chromosomal titratable supercoiling (124) . Thus, a homeostatic relationship between gyrase expression and DNA supercoiling is not sufficient to explain all of the data ( Table 1 ). An interesting speculation is that topoisomerase I directly affects gyrase gene expression.
Gyrase expression is also affected by the himA gene product, one of the components of a protein complex important for bacteriophage lambda integrative recombination. In a himA deletion mutant, gyrA expression is reduced about fourfold whereas gyrB expression is unchanged (40) . It is interesting to note that supercoiling activity in the himA deletion mutant, as measured by introduction of titratable supercoils into superinfecting bacteriophage lambda, is the same as that in wild-type strains (35, 40) . This finding supports the idea discussed above that the concentration of the gyrB protein is more important than the concentration of the gyrA protein in controlling supercoiling. The himA deletion, presumably through its effect on lowering production of gyrA protein, does have an effect on gyrase activity if placed in a strain having a temperature-sensitive gyrB mutation: supercoiling activity, measured with superinfecting bacteriophage lambda in cells incubated at restrictive temperature, is lower than that in cells having only the gyrB mutation (35, 40) . Another aspect of the himA-gyrA relationship involves the SOS response to DNA-damaging agents (for review of the SOS response, see reference 81). The himA gene appears to be under lexA control and becomes induced when cells are treated with UV light (99) . The data discussed in the previous paragraph lead us to expect gyrA protein production also to increase during the SOS response. Surprisingly, Menzel and Gellert (98) found that the absence of the recA gene, which is needed for induction of SOS-controlled genes, has no effect on induction of gyrA or gyrB by nalidixic acid or UV irradiation. Perhaps the himA protein is at saturating concentration with respect to gyrase expression in wild-type cells before induction of the SOS response.
ROLE OF TOPOISOMERASES AND SUPERCOILING IN
DNA REPLICATION Three aspects of DNA topology are important when considering DNA replication. First, a swivel problem arises during movement of a replication fork. DNA unwinding and strand separation are expected to generate torsional tension ahead of replication forks in topologically constrained DNA molecules, and without a topoisomerase acting as a swivel, the torsional strain will eventually become so great that fork movement will stop. Second, some proteins involved in initiation of DNA replication may require a supercoiled substrate for binding. Third, the persistence of helical overlaps after completion of a round of replication (Fig. 2) will leave daughter chromosomes catenated (interlinked). Proper chromosome segregation may require a decatenating activity. The following paragraphs review evidence that topoisomerases play roles in all three of these aspects of DNA replication.
Elongation Phase of Replication Participation of gyrase in replication fork movement is more a logical construct than a phenomenon well documented by in vitro studies. One line of support for the concept that negative supercoils facilitate fork movement is found in an observation by Liu and Wang (83 (25) , and in so doing the drug also decreases rates of DNA synthesis (25) . The Interpretation of the action of oxolinic and nalidixic acids relies heavily on how these drugs interact with gyrase in vitro. The two drugs appear to trap a gyrase-DNA reaction intermediate in which gyrase has cleaved its DNA substrate and the gyrA protein has become covalently bound to the DNA (reviewed in reference 120). A similar reaction probably occurs in vivo since cleaved DNA can be isolated from permeabilized (122) and intact (56, 145) cells treated with the drugs. In vivo a saturable number of gyrase-DNA complexes exist, as determined by measurement of DNA fragment lengths, and the number of cleavage events correlates with the extent of inhibition of DNA synthesis (145) . At low but saturating concentrations of oxolinic acid, little or no loss of supercoiling occurs (145) . Thus, formation of drug-gyrase-DNA complexes appears responsible for inhibition of DNA replication.
Quantitatively, inhibition of DNA synthesis by oxolinic acid does not fit simple models. If one views DNA as moving through a stationary replication apparatus, formation of a single complex anywhere on the chromosome might rapidly block DNA movement and therefore replication, much in the way 32P decay-generated strand scission is thought to block replication from a distance (8) . In the case of oxolinic and nalidixic acids this explanation seems unlikely since there are on average about 50 gyrase-DNA targets for oxolinic acid scattered over the genome, and the degree of inhibition of DNA synthesis is proportional to the number of complexes formed per genome, not the number of genomes with a single drug-gyrase-DNA complex (145) . Alternatively, one could imagine that the replication apparatus moves along the DNA; movement of replication forks could be interrupted whenever a fork encounters a drug-gyrase-DNA complex. This explanation must take into account the observation that inhibition is rapid even at very low drug concentrations, concentrations at which only partial inhibition occurs. These concentrations are so low that complexes, if randomly distributed among 50 targets, are not expected to be near enough to forks to cause rapid, but partial, inhibition. A third speculation is that gyrase preferentially binds near replication forks in addition to being distributed over the entire genome; complex formation near forks would quickly block DNA replication. Since gyrase preferentially binds to relaxed DNA (54) and DNA near replication forks is expected to be relaxed due to discontinuous synthesis and DNA unwinding, it is reasonable for gyrase to be concentrated near forks. Consistent with this notion are the observations that pulse-labeled DNA is cleaved by oxolinic acid into fragments smaller than those from long-term-labeled DNA (24) and inhibition of DNA synthesis exhibits biphasic kinetics (24, 28 [82, 149] ) cause a delay in acceleration of the T4 DNA synthesis (107) . Since these mutations reduce the number of replication forks but not the rate offork movement (93) , it appears that the T4 topoisomerase plays a role in initiation of phage replication. So far supercoiling activity has not been found to be associated with the T4 topoisomerase (76) , but the host cell gyrase will partially compensate for the loss of activity in vivo: inactivation of gyrase by coumermycin Al blocks nearly all phage DNA synthesis in T4 topoisomerase mutants (92) . Gyrase, however, is not required for wild-type phage replication, for with these phages replication is affected little by coumermycin Al (92) .
Our understanding of how supercoiling affects initiation of bacterial chromosome replication may soon be clarified. An in vitro system for studying initiation of replication has been developed in which plasmid replication requires the chromosomal origin of replication, the dnaA protein, and a number of other factors (37 (23) . Since topoisomerases appear to play a role in chromatin formation in eucaryotic cells (43a, 134a) , it is reasonable to postulate that a similar phenomenon occurs in bacteria which provides specificity and stimulation for dnaA protein action.
Physiological studies support the general concept that gyrase and supercoiling are involved in initiation of replication. In one type of investigation temperature-sensitive gyrase mutants of E. coli, incubated at restrictive temperature, exhibit reduced rates of DNA synthesis without showing a decrease in elongation rates (32, 115) . Thus, it appears that initiation is blocked under these conditions. Antibiotic studies with Bacillus subtilis are also consistent with the hypothesis. Germinating spores from a thymine-requiring strain develop the potential to initiate replication, but no replication occurs until thymine is supplied. Treatment with coumermycin A1, but not nalidixic acid, before addition of thymine leads to a loss of initiation potential (111) . In this case the conclusion that DNA supercoiling is involved in this phenomenon relies on titratable supercoiling measurements made with E. coli: coumermycin A1 causes DNA relaxation (25) , whereas oxolinic acid, at moderate concentrations, does not (145) .
Several intriguing genetic observations with a temperature-sensitive dnaA initiation mutant have also been suggested as evidence for involvement of gyrase or supercoiling or both in the initiation reaction. First, the dnaA46 mutant, growing at permissive temperatures, is three to four times more sensitive to inhibitors of gyrase than is the appropriate wild-type strain (31) . Second, spontaneous novobiocin-or nalidixic acid-resistant mutations arise in the dnaA46 strain at a frequency 20 to 30 times lower than that observed in the wild-type strain (31) . Third, when the dnaA46 mutation is suppressed by an RNA polymerase mutation (rpoB), this double mutant exhibits a three-to fourfold-lower sensitivity to novobiocin than does the strain having only the dnaA46 mutation (32) . Since the dnaA46 mutation affects the thermal stability of the gene product itself (155) , it is unlikely that these three observations arise from a promoter mutation making dnaA particularly sensitive to DNA superhelical tension. Perhaps RNA polymerase and the dnaA protein interact in a way that is sensitive to DNA superhelical tension.
Termination of Replication Evidence for gyrase participation in daughter chromosome resolution also comes from inactivation of gyrase (146a). The sedimentation coefficients of nucleoids isolated from a temperature-sensitive gyrase mutant increase after cells are shifted to the nonpermissive temperature (146a, 147) . Microscopic examination of nucleoids isolated from the mutant revealed that almost 90% of them become dumbbell-shaped doublets (in the comparable wild-type strain the amount is <20%) (146a) . These doublet nucleoids probably correspond to daughter chromosomes that have failed to segregate in the absence of gyrase activity. While the block in chromosome segregation could be due to the inability either to complete a round of replication or to decatenate interlinked chromosomes, incubation of isolated doublet nucleoids with purified gyrase causes many of the doublets to separate into singlets; gyrase activity appears to be sufficient to separate the daughter chromosomes in vitro under conditions in which no DNA synthesis should occur.
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The simplest interpretation of these results is that the decatenating activity of gyrase is required for proper chromosome segregation.
Plasmid Replication In Vivo Relationships between plasmid replication and topoisomerase activity have also been explored by inhibiting gyrase. Two differences have been found between plasmids and the host chromosome. First, bacterial strains can be cured of some types of plasmids by treatment with sublethal concentrations of inhibitors of the gyrB protein (9, 58, 96, 153, 170, 171) or by incubation of temperature-sensitive gyrB mutants at intermediate temperatures (36, 170) . Among the plasmids reported to be sensitive to these treatments are ColA, CoIV, pBR322, R28K, Rldrd-19 (in some host strains), Flac, and pMG110. Second, higher concentrations of oxolinic acid are required to inhibit ColEl replication than chromosomal replication (Pruss, unpublished data). So far no unifying theme has emerged which explains these differences between plasmid and chromosome replication.
ROLE OF TOPOISOMERASES AND SUPERCOILING IN
GENE EXPRESSION An understanding of the relationships between supercoiling and transcription developed primarily from in vitro studies. Hayashi and Hayashi (52) first noticed that the initial rate of RNA synthesis is about three times higher from a supercoiled bacteriophage template than from a relaxed one. Subsequently, DNA topoisomers having different superhelical densities were used to show a proportionality between the level of DNA supercoiling and transcriptional activity (4, 132, 164) . Two lines of evidence indicate that superhelical tension facilitates initiation of transcription.
First, chain initiation, measured by incorporation of y_32P labeled ATP and GTP, is greater with a supercoiled template (132, 133) . Second, the maximum number of RNA polymerase molecules that can form heparin-resistant complexes with DNA, complexes capable of initiating RNA synthesis, is greater with supercoiled DNA (133) .
In vitro studies also showed that superhelical tension does not affect all genes equally. In the case of bacteriophage lambda DNA, increasing supercoiling raises the amount of RNA synthesis and lowers the relative amount of early gene transcription (4) by increasing transcription from promoters not used on linear DNA (3). In another approach, specific inhibitors were used to assess the effect of gyrase on coupled transcription and translation in a DNA-directed, cell-free system (175) . Two types of DNA were examined. In the first case, relaxed plasmid DNA was added to the reaction mixture. Novobiocin blocked an endogenous supercoiling activity and reduced the relative synthesis of some proteins (colicin El, tetracycline resistance protein) but not others (,-lactamase). In the second case, DNA from lambda transducing phages was used as a template. Expression from the lacZ and rrnB promoters, but not from the trp promoter, was reduced by novobiocin. In both of these cases gyrase was shown to be the target of novobiocin because little drug effect was observed when the cell-free system was prepared from mutants containing novobiocin-resistant gyrase. However, the conformation of the lambda DNA templates was not determined; these DNAs may have been linear. Since linear plasmid DNA also shows selective inhibition of gene expression by novobiocin, the interesting possibility exists that gyrase introduces localized superhelical tension into linear DNA molecules, a phenomenon that may be relevant to transcription of linear bacteriophage DNA in vivo (21, 30 (125) found that phage DNA in these mutants has a template efficiency four to five times that found in cells infected with wild-type phages. Thus, it appears that the effect of superhelical tension on transcription in vivo is quantitatively similar to that observed in vitro.
The second type of study linked gyrase to transcription. Antibiotics (29, 46, 134) and temperature-sensitive mutations (32a, 75, 100, 114, 115) affecting gyrase activity reduce levels of RNA synthesis in vivo. The antibiotics are selective in their inhibitory action: cells treated with inhibitors exhibit reduced expression of some genes, increased expression of others, and unchanged expression of still others (Table 2) .
Since coumermycin Al and temperature-sensitive gyrase mutations cause a loss of titratable supercoils from bacterial nucleoids (25, 147, 161) and plasmids (65, 84, 100, 121) , it is likely that these two treatments affect transcription by relaxing DNA superhelical tension. Indeed, there is a rough correlation between the change in total RNA synthesis rate and the change in titratable supercoils when cells are treated with coumermycin A1 (88) .
Inhibition of gyrase by oxolinic and nalidixic acids presents a more complicated situation, for the cellular response is very dependent on drug dose. At low drug concentrations, DNA synthesis is drastically inhibited (45, 46) , DNA cleavage sites become saturated with drug molecules (145), a small fraction of total RNA synthesis is inhibited (88) , and little change in average DNA supercoiling occurs (88, 145) . At high drug concentrations, chromosome supercoiling decreases (88), total RNA synthesis is substantially reduced (46) , and the expression of some genes is inhibited (135, 137, 142) . Moreover, the SOS response (reviewed in reference 81) is induced (see next section). Whereas control experiments with drug-resistant mutants support the contention that inhibition of gyrase is responsible for selective inhibition of certain genes by oxolinic and nalidixic acids, the relationship to superhelical tension is not clear: we have observed a counterexample in which oxolinic acid causes an increase in titratable supercoiling while at the same time causing a decrease in total RNA synthesis (88) . Perhaps the oxolinic acid-gyrA protein-DNA complexes discussed above block RNA synthesis as well as DNA synthesis.
The third physiological approach has focused on topoisomerase mutations that alter steady-state levels of titratable supercoiling ( Table 3) . The supX mutations, the first group discovered (108), were identified in S. typhimurium by their ability to suppress the leu-500 promoter mutation. In this system, the suppressor effect arises from a loss of a gene mapping near cys and trp, almost 50 min away from the leucine operon. When topA was mapped to this same region (148, 156) , it became apparent that supX action resulted from the loss of topoisomerase I activity (157) . It is likely that supX acts to change supercoiling: supX mutants have higher-than-normal levels of titratable supercoiling (Pruss, unpublished data) . In E. coli, topA mutations also exist (148) that appear to exhibit elevated levels of ,B-galactosidase induction under certain conditions (148); these cells also have higherthan-normal levels of titratable supercoiling (124) . Another example of altered supercoiling affecting gene expression is associated with compensatory mutations arising in gyrase in response to topA deletions (22, 124) . As mentioned in a previous section, these mutations result in lower-than-normal levels of titratable supercoiling (124) . In these gyrase mutants the bgl operon, which is not expressed in wild-type strains, becomes inducible (22) .
Whereas it is clear that levels of supercoiling or topoisomerase activity affect the expression of a few genes (Tables 2   TABLE 2 ' S. typhimurium.
f Bacteriophage. 8 In some cases, trp expression is inhibited by drugs affecting gyrase, whereas in other cases it is not. and 3), in most cases it is not known whether the effect is direct or mediated by altered expression of other genes. Nor is the general scope of the effect known. However, the availability of topoisomerase mutants in which titratable supercoiling is either higher or lower than normal now makes it possible to survey the relative abundance of a large number of proteins to determine whether the level of supercoiling found in wild-type cells is optimal for expression of most genes.
CELLULAR RESPONSES TO NALIDIXIC ACID Inhibitors of gyrase are bacteriocidal (45, 134, 144) ; in retrospect, this is not surprising since gyrase and supercoiling play a central role in bacterial chromosome structure and function. However, the bacteriocidal effect, especially in the cases of oxolinic and nalidixic acids, arises from more than a simple absence of gyrase activity. As mentioned above, these drugs form complexes in which the gyrA protein and the drug are bound to DNA (41, 101, 105, 106, 145, 150, 151, 158), and it is likely that these complexes act as barriers to replication fork movement: DNA synthesis is rapidly inhibited when cells are treated with nalidixic or oxolinic acid (46) . Blockage of DNA replication, which is readily reversed by removal of the drug (50, 66) , leads to induction of the SOS regulatory pathway (for review, see reference 81). As a result, cell division stops and some proteins thought to participate in DNA repair increase in abundance. It is not known how nalidixic acid-induced lesions are repaired. The SOS response is probably involved since mutations in some of the genes of that pathway increase the bacteriocidal effect of nalidixic acid (Table 4) . A simplified version of the SOS response, as it pertains to nalidixic acid, is illustrated in Fig.  3 .
The recA gene is the most extensively studied component of the SOS regulatory pathway, and induction of recA is commonly used as an assay for the response. In the case of nalidixic acid, inhibition of DNA synthesis is one factor in the induction of recA, for cells undergoing little or no DNA replication (temperature-sensitive dnaA mutants incubated at restrictive temperature) show little induction of recA after drug treatment (50, 80) . Factors other than inhibition of DNA synthesis are probably also involved in recA induction, for the same amount of inhibition of DNA synthesis by thymine starvation induces less recA protein than does inhibition by nalidixic acid (50) . Moreover, higher nalidixic acid concentrations induce more recA protein than lower ones even when the extent of inhibition of DNA synthesis is roughly the same (50) . One testable hypothesis is that the decrease in titratable supercoiling associated with high concentrations of the drug (88) enhance expression of recA.
Generating the signal for induction of recA by nalidixic acid requires the presence of wild-type alleles of recB and recC (49, 79) . Since the recB and recC gene products exhibit DNA exonuclease V activity in vitro (for review, see 154), the idea developed that exonuclease V degrades DNA (34, 143) when DNA synthesis is rapidly blocked. In this model, DNA degradation would create an oligonucleotide signal that would in turn convert the recA protein into a catalyst of proteolytic cleavage of the lex protein, the repressor of recA ( Fig. 3 ; see reference 81 for review of lex and recA interactions). Since DNA degradation is potentially harmful and probably contributes to the cytotoxicity of nalidixic acid (15, 16, 34, 49, 66, 130) , the presence of wild-type recB and recC alleles might not always be favorable for survival. Such a case has been reported; wild-type cells are more sensitive than recB and recC mutants to inhibitors of gyrase if the cells VOL. 48, 1984 on October 16, 2017 by guest http://mmbr.asm.org/ are pretreated with UV irradiation (128) . This UV effect is exacerbated by a mutation in recA (127), perhaps because the recA protein blocks exonuclease V-dependent DNA degradation (14, 90, 136, 167, 168) . Such action by the recA protein might also explain why high concentrations of nalidixic acid, which lead to high levels of recA induction, exhibit less DNA degradation (34) and less cell death (18, 169) than lower concentrations of the drug.
One of the consequences of the SOS response to nalidixic acid is that cell division is blocked. The effect appears to be mediated by the lex protein, which normally acts as a repressor of the sfiA gene (Fig. 3) . The target of the sfiA protein appears to be the sfiB (ftsZ) protein (86) , and the latter is probably required for cell division. Thus, nalidixic acid indirectly leads to induction of sfiA, inactivation of the sfiB protein, and cessation of cell division. In a sfiB mutant, the sfiB protein might not be readily inactivated by the sfiA protein, explaining the observation that a sfiB mutation delays inhibition of cell division by nalidixic acid (6) .
Recovery of normal cell division after removal of nalidixic acid may involve the lon protein. Mutations in Ion lead to nalidixic acid-induced lethal filmentation (66), a situation in which cells grow lengthwise but do not divide. The lon protein exhibits protease activity in vitro (11, 12) , and one of its functions may be to degrade the sfiA protein after DNA damage has been repaired.
The recF pathway is also involved in cell survival during treatment with nalidixic acid; recF mutants are hypersensitive to the drug and recBCF triple mutants are more sensitive to nalidixic acid than are either recBC or recF mutants (95) . Little can be said about the role of recF. The wild-type allele is not required for induction of recA by nalidixic acid (67, 97, 141) , and under some circumstances it even lowers the level of induction (67) . In contrast, induction of recA by coumermycin A1 requires the presence of a wild-type recF allele (141) .
TOPOISOMERASES, RECOMBINATION, AND REPAIR Generalized Recombination
Generalized recombination is mediated by the recA gene product, and this protein is known to unwind DNA in vitro (112, 173) . Thus, we expect negative superhelical tension to facilitate recombination through its effect on DNA unwinding. Indeed, recA-dependent recombination in a spheroplast transfection system occurs between single-stranded fragments of XX174 DNA and circular XX174 replicative intermediate at higher frequencies if the replicative form DNA is supercoiled (57) .
Two observations suggest that gyrase activity may affect recombination. First, recombination involving UV-irradiated, superinfecting bacteriophage lambda DNA (53) or transformation in Streptococcus sanguis (129) is reduced in vivo by inhibitors of gyrase. These inhibitors also lower intramolecular recombination in plasmids in an in vitro, recAdependent system (72) . Second, recombination after conjugation is reduced in gyrB mutants (161) . However, generalized recombination is not very sensitive to small changes in DNA supercoiling: topoisomerase mutants having either 25% higher-or 25% lower-than-normal levels of titratable supercoiling (124) have similar recombination frequencies when measured by P1-mediated transduction (148) .
Site-Specific Recombination Integration and excision of bacteriophage lambda and resolution of cointegrates by transposons involve recombi- The development of an in vitro integrative recombination system for lambda uncovered the need for supercoiled DNA (104) and led to the discovery of gyrase (42) . It was then found that inhibitors of gyrase (69) or mutations in gyrB (himB; 36, 40) restrict lambda integration, indicating that the requirement for supercoiling also holds in vivo. Integrative recombination can be carried out with in vitro reaction mixtures containing purified lambda int gene product (Int), purified integration host factor (the product of E. coli genes himA and hip), and DNA containing two specialized nucleotide sequences, attP from the phage and attB from the bacterium (110, 123) .
Nash and his colleagues (70, 110, 123) (69, 70) leads to cleavage of one DNA strand from each parent followed by swiveling of the parental helices around each uncut strand and ligation of realigned strands. This Holliday junction is then resolved by a second round of Int-dependent cleavage, swiveling, and ligation of the remaining parental strands. It is not clear which steps are accelerated by supercoiling. An important symmetry consideration arises from the observation that supercoiling of attP-containing, but not attBcontaining, DNA stimulates recombination (103, 123) . An attractive idea is that attP wraps around Int and that supercoiling favors this event much in the way it favors wrapping of DNA around histones during formation of nucleosomes (123) .
Resolvase from transposon Tn3 also displays topoisomerase activity. This protein resolves a supercoiled cointegrate into two catenated, supercoiled rings (19, 74) . Recombination mediated by resolvase is strongly favored in supercoiled DNA molecules (131) . During the reaction, a small amount of relaxation occurs in both the parental DNA and the recombinant catenanes (74) . Both relaxation and recombination by resolvase require the same substrate, two res sites oriented as direct repeats. Neither relaxation nor recombination occurs with DNAs having zero, one, or even two res sites if oriented head to head (19, 74) . Thus, resolvase is the only topoisomerase which shows strict nucleotide sequence specificity. Moreover, resolvase relaxes and recombines DNA only if the two res sites are on the same DNA molecule (74) .
Gyrase-Mediated Illegitimate Recombination Ikeda and co-workers (60, 61, 109) observed that illegitimate recombination occurs in vitro when an ampicillinresistant plasmid (pBR322) is present in a bacteriophage lambda packaging system: Ampr transducing phages arise at a frequency of about . Surprisingly, addition of oxolinic acid to the packaging system stimulates the recombination event by about 10-fold. Coumermycin Al blocks the stimulatory effect of oxolinic acid. Thus, it has been suggested that gyrase participates in illegitimate recombination, perhaps through a mechanism involving gyrase subunit exchange. During gyrase-DNA interactions, two gyrA proteins and two gyrB proteins are thought to form a complex with DNA that results in transient double-strand cleavage (for reviews, see references 17 and 38). Exchange of gyrA protein-DNA fragments at this stage would lead to recombination. Oxolinic acid interacts with the gyrA protein to trap a reaction intermediate in which the phosphodiester bonds in DNA are broken; by lengthening the lifetime of the reaction intermediate, oxolinic acid could stimulate subunit exchange. Since gyrase does not exhibit strict nucleotide sequence specificity, recombination events could occur at a wide variety of locations on both pBR322 and lambda. Heteroduplex and nucleotide sequence analyses of recombinants show this to be the case. If a cascade of subunit exchange occurs, deletions are expected to arise in the recombinants (Fig. 4) ; this too has been observed. As predicted by the subunit exchange model, mutations in genes involved in recombination have no effect on the stimulation of illegitimate recombination by oxolinic acid.
Some illegitimate recombination events occurring in vivo are also most easily interpreted by using the gyrase subunit exchange model (71, 91 combination with protein-denaturing agents, produces double-strand DNA cleavage (145) . Nucleotide sequences determined from a recombinant formed in vivo (91) have been included in Fig. 4 to illustrate a possible mechanism.
DNA Repair Relationships between DNA repair and supercoiling have been investigated by using mutations that alter levels of titratable supercoiling, but so far no simple correlation has emerged. Both gyrB mutations and inhibitors of gyrase reduce supercoiling (25, 147, 161) ; in one case the mutation lowers sensitivity to UV irradiation (161) , whereas in others the inhibitor reduces repair of UV-induced damage (53) . Mutations in topA, some of which raise levels of supercoiling (124; Pruss, unpublished data), raise sensitivity to UV irradiation (118, 148) . But UV sensitivity may not arise from supercoiling, for sensitivity is also observed in a topA mutant (DM800 [148] ) having lower-than-normal levels of supercoiling (124) , levels which arise from an additional mutation in gyrB (22) . It is now necessary to determine which of these effects are due to altered expression of genes involved in repair and which arise from alterations in the DNA that acts as a substrate for repair enzymes. Another approach is to ask how DNA damage affects topoisomerase activity. In the case of topoisomerase I, supercoiled DNA containing small amounts of UV-induced damage is not efficiently relaxed by topoisomerase I in vitro (119) 
CONCLUDING REMARKS
Biochemical and physiological studies of topoisomerases have led to the following general view of bacterial chromosome structure and function. Bacterial chromosomal DNA is circular (7), so topoisomerases are able to activate the DNA by maintaining superhelical tension in it. Gyrase introduces tension by lowering DNA linking numbers (42) and topoisomerase I modulates the level (124) by increasing them (163) . The level of tension is tightly controlled, and even small alterations induced by changes in temperature seem to be corrected by topoisomerase action (43b) . One of the reasons for such tight control of superhelical tension appears to involve gene expression, for expression of certain genes is sensitive to changes in supercoiling or topoisomerase activity or both (Tables 2 and 3 ). Since nicks or gaps in DNA would lead to relaxation and would adversely affect gene expression, the chromosome is divided into about 50 topologically independent domains (139, 172) to confine relaxation to small (100-kilobase pair) regions. Gyrase is distributed along the DNA at 100-kilobase pair intervals (145) , which correspond to about one gyrase per domain. This distribution of gyrase does not diminish when DNA, RNA, or protein synthesis is inhibited (unpublished data), so gyrase is able to maintain superhelical tension under a variety of conditions. As a consequence of domains and gyrase, relaxation associated with discontinuous DNA synthesis is restricted to only 2% of the chromosome at any given time. Thus a new round of replication, which may require supercoiled DNA for initiation, can begin before the previous round finishes. By examining the events at the end of a round of replication, we see one of the costs of chromosome circularity: the need to unlink daughter chromosomes. This event appears to require gyrase activity (Steck and Drlica, in press ).
Although we are beginning to understand topoisomerases and supercoiling, a number of questions about their roles in chromosome structure and function remain unanswered. For example, we do not know how topological domains are established, whether specific nucleotide sequences are involved, or if superhelical tension is the same in each. Nor do we know whether cells respond to unfavorable environmental conditions by changing superhelical tension so certain genes can be induced. Finally, we would like to know what role histone-like proteins and nucleosomes play in bacterial DNA topology so we can relate bacterial studies to eucaryotic systems in which nucleosomes tend to dominate our thinking.
